
Breast Cancer: Dual HER2 Blockade May Reduce Need for Anthracyclines in Subgroup of Women
Author(s) -
Robert H. Carlson
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000410632.00445.ae
Subject(s) - taxane , breast cancer , medicine , trastuzumab , anthracycline , oncology , blockade , chemotherapy , cancer , family medicine , receptor